MedImmune

With one of the largest, most robust pipelines in the industry — including more than 120 research projects and product candidates — we comprise nearly half of AstraZeneca’s overall R&D portfolio. We are focused on three core therapeutic areas: Oncology; Respiratory, Inflammation and Autoimmune; and Cardiovascular and Metabolic Disease. But, we also are opportunity-driven in Infectious Disease.
Company Growth (employees)
Type
Private
HQ
Gaithersburg, US
Founded
1987
Size (employees)
4,069 (est)
MedImmune was founded in 1987 and is headquartered in Gaithersburg, US

MedImmune Office Locations

MedImmune has offices in Gaithersburg, Great Abington and Mountain View
Gaithersburg, US (HQ)
1 Medimmune Way
Mountain View, US
319 N Bernardo Ave

MedImmune Data and Metrics

Summary Metrics

Founding Date

1987

MedImmune Median Salaries

Source: 145 public H-1B filings from MedImmune

Traffic Overview of MedImmune

MedImmune Online and Social Media Presence

MedImmune News and Updates

AstraZeneca and Abpro join up on cancer research

AstraZeneca's biological arm MedImmune and US life sciences group Abpro have joined forces on a new research collaboration that will be spunout as a new company. Called AbMed, it will hold the development and commercialization rights while MedImmune gets a minority stake and a slate of unspecifie…

AstraZeneca licences Crohn's disease treatment to Allergan for $1.5bn

Drug giant AstraZeneca has struck a deal with Ireland-based pharma firm Allergan to licence a treatment for Crohn's disease. Allergan will pay $250m upfront and make further payments of up to $1.27bn depending on how the drug performs.  AstraZeneca's shares climbed on the news and were earlier…

MedImmune Company Life and Culture

You may also be interested in